3//SEC Filing
RiverVest Venture Fund III, L.P. 3
Accession 0000899243-21-015406
CIK 0001637715other
Filed
Apr 7, 8:00 PM ET
Accepted
Apr 8, 5:37 PM ET
Size
12.5 KB
Accession
0000899243-21-015406
Insider Transaction Report
Form 3
Holdings
- (indirect: See footnotes)
Series A Preferred Stock
→ Common Stock (1,100,765 underlying) - 279,342(indirect: See footnote)
Common Stock
- (indirect: See footnotes)
Series B Preferred Stock
→ Common Stock (829,113 underlying)
RiverVest Venture Fund III, L.P.
10% Owner
Holdings
- 279,342(indirect: See footnote)
Common Stock
- (indirect: See footnotes)
Series A Preferred Stock
→ Common Stock (1,100,765 underlying) - (indirect: See footnotes)
Series B Preferred Stock
→ Common Stock (829,113 underlying)
RiverVest Venture Fund IV, L.P.
10% Owner
Holdings
- 279,342(indirect: See footnote)
Common Stock
- (indirect: See footnotes)
Series A Preferred Stock
→ Common Stock (1,100,765 underlying) - (indirect: See footnotes)
Series B Preferred Stock
→ Common Stock (829,113 underlying)
Footnotes (7)
- [F1]RiverVest Venture Fund III, L.P. ("RiverVest III") owns 265,263 shares of Common Stock. RiverVest Venture Fund III (Ohio), L.P. ("RiverVest (Ohio) III") owns 14,079 shares of Common Stock.
- [F2]Each share of Series A Preferred Stock and Series B Preferred Stock has no expiration date and are convertible at any time at the election of the holder without payment of further consideration. Each share of Series A Preferred Stock and Series B Preferred Stock will automatically convert into 1 share of Common Stock for each 4.4748 shares of Preferred Stock based upon the conversion price currently in effect. Share numbers (including those noted in the footnotes below) give effect to such conversion in connection with the closing of the Issuer's initial public offering.
- [F3]RiverVest III owns 62,831 shares of Series A Preferred Stock. RiverVest (Ohio) III owns 3,334 shares of Series A Preferred Stock. RiverVest Venture Fund IV, L.P. ("RiverVest IV") owns 1,034,600 shares of Series A Preferred Stock.
- [F4]The shares held by RiverVest III are indirectly held by RiverVest Venture Partners III, L.P. ("RiverVest Partners III"), which is the general partner of RiverVest III. The shares held by RiverVest (Ohio) III are indirectly held by RiverVest Venture Partners III (Ohio), LLC ("RiverVest Partners (Ohio) III"), which is the general partner of RiverVest (Ohio) III. RiverVest Partners III is the sole member of RiverVest Partners (Ohio) III. RiverVest Venture Partners III, LLC is the general partner of RiverVest Partners III.
- [F5]The individual managers of RiverVest Ventures Partners III, LLC are Thomas C. Melzer, Jay Schmelter and John P. McKearn, Ph.D. RiverVest Partners III, RiverVest Partners (Ohio) III, RiverVest Venture Partners III, LLC and each of the individual managers share voting and dispositive power with regard to the Issuer's securities directly held by RiverVest Venture Fund III, L.P. and RiverVest Venture Fund III (Ohio), L.P.
- [F6]RiverVest IV owns 829,113 shares of Series B Preferred Stock.
- [F7]The shares held by RiverVest IV are indirectly held by RiverVest Venture Partners IV, L.P., its general partner ("RiverVest Partners IV"). RiverVest Venture Partners IV, LLC is the general partner of RiverVest Partners IV. The individual managers of RiverVest Ventures Partners IV, LLC are Jay Schmelter, John P. McKearn, Ph.D. and Niall O'Donnell, a member of the Issuer's board of directors. RiverVest Partners IV, RiverVest Venture Partners IV, LLC and each of the individual managers share voting and dispositive power with regard to the Company's securities directly held by RiverVest IV.
Documents
Issuer
Reneo Pharmaceuticals, Inc.
CIK 0001637715
Entity typeother
IncorporatedDE
Related Parties
1- filerCIK 0001601559
Filing Metadata
- Form type
- 3
- Filed
- Apr 7, 8:00 PM ET
- Accepted
- Apr 8, 5:37 PM ET
- Size
- 12.5 KB